ChartRow logo
NVS
Novartis AGStock · Health Care
$154.21−$0.23 (-0.15%)as of market close, Aug 6, 2026
CompareLLYUNHJNJABBVISRGTMO

NVSNovartis AG stock price, chart and key statistics

Key stats

Price data

Price
$154.21
Change YTD
+11.85%
Market cap
294.3B
Enterprise value
283.6B
Shares outstanding
1.9B
52W low
$113.48
52W high
$170.46
From 52W high
-9.53%
From 52W low
+35.89%
52W range
71%
Beta
0.46

Volume

Rel volume
0.55×
30D volume
1.9M
30D $ vol
295.9M

Fundamentals

EPS (ttm)
$7.15
FCF (ttm)
19.1B
FCF/share
$10.03
Book value/share
$24.18
ROE
30.28%
ROA
12.59%
Current ratio
1.12

Growth (CAGR, ttm) · 10Y

Net income
n/a
Shares
n/a

Per-share growth (CAGR, ttm) · 10Y

EPS
n/a
Book value/share
n/a
Dividend/share
n/a
Price
+7.55%
Total return
+11.37%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
21.6×
P/OI (ttm)
16.7×
Fwd P/E
15.6×
P/B (mrq)
6.4×
P/FCF (ttm)
15.4×
EV/EBITDA (fy)
16.1×
FCF yield (ttm)
6.51%
Dividend yield (fwd)
2.66%
Dividend/share (fwd)
$4.10
Buyback yield (realized, 1y)
3.39%
Shareholder yield (realized, 1y)
6.05%
Buyback yield (cash, ttm)
3.10%
Shareholder yield (cash, ttm)
5.76%

Vs own 10Y history

P/E
55th
P/OI
11th
P/B
98th

Bar = where today's multiple sits in NVS's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance · price return

1D
-0.15%
1W
-2.67%
1M
-0.62%
3M
+3.94%
YTD
+11.85%
1Y
+30.99%
5Y
+67.27%

Financial statements

Open full NVS financials →

Related Health Care

1M
TickerThemePrice1M30D $Vol
AZN
AstraZeneca PLC
$161-14.90%597.2M
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
$52.17-0.67%223.6M
NVO
Novo Nordisk A/S
$45.97-5.97%575.6M
ARGX
argenx SE American Depositary Shares
$875-4.37%273.2M
SNY
Sanofi ADS
$42.89+0.26%152.5M
RVMD
Revolution Medicines Inc.
$198+4.24%463.3M
TEVA
Teva Pharmaceutical Industries Limited American Depositary Shares
$34.81+4.72%179.6M
NTRA
Natera Inc.
$265-3.28%360.8M

Novartis AG (NVS) trades at $154.21 with a live price and an interactive chart covering 29+ years of daily price history, plus key valuation metrics. ChartRow also publishes NVS's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full NVS financial statements →